4.4 Article

INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF SUBRETINAL FLUID ASSOCIATED WITH CHOROIDAL OSTEOMA

Related references

Note: Only part of the references are listed.
Article Ophthalmology

Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin)

Hamid Ahmadieh et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2007)

Article Ophthalmology

Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA study): Results of a phase 1 dose-escalation study

Rogerio A. Costa et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)

Article Ophthalmology

Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration

Ziad F. Bashshur et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)

Article Ophthalmology

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia

QD Nguyen et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2005)

Letter Ophthalmology

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia

QD Nguyen et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2005)

Article Ophthalmology

Choroidal osteoma - Observations from a community setting

DJ Browning

OPHTHALMOLOGY (2003)

Article Ophthalmology

Review: Sclerochoroidal calcification - The 2001 Harold Gifford Lecture

JA Shields et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2002)